Patent Update Cardiovascular & Renal: Treatments for myocardial ischaemia
- 1 May 1994
- journal article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 4 (5), 531-542
- https://doi.org/10.1517/13543776.4.5.531
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Plasma endothelin-1 in acute myocardial infarction with heart failureAmerican Heart Journal, 1993
- Regional vasodilation to endothelin-1 is mediated by a non-ETA receptor subtype in the anaesthetized rat: effect of BQ-123 on systemic haemodynamic responsesEuropean Journal of Pharmacology, 1992
- Circulating endothelin in acute ischaemic syndromes.Heart, 1992
- Augmented contractile response to endothelin and blunted endothelium-dependent relaxation in post-ischemic reperfused coronary arteries.Japanese Circulation Journal, 1992
- Plasma endothelin levels during myocardial ischemia and reperfusionLife Sciences, 1991
- Cytotoxic effect of endothelin-1 during ‘simulated’ ischaemia in cultured rat myocytesEuropean Journal of Pharmacology, 1991
- Increased plasma endothelin-1 in the early hours of acute myocardial infarctionJournal of the American College of Cardiology, 1991
- Ischaemia causes externalization of endothelin-1 binding sites in rat cardiac membranesBiochemical and Biophysical Research Communications, 1989
- Endothelin is a positive inotropic agent in human and rat heart in, vitroBiochemical and Biophysical Research Communications, 1989
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988